Filter
8788
Filtered Results: 8788
Text search:
patient
information
Featured
Recommendations
852
New Publications
2202
Language
Document type
No document type
4872
Studies & Reports
1250
Guidelines
1228
Manuals
463
Strategic & Response Plan
284
Fact sheets
259
Training Material
171
Situation Updates
107
Resource Platforms
47
Brochures
42
Infographics
37
Online Courses
19
Videos
8
App
1
Countries / Regions
India
430
Global
294
Kenya
231
South Africa
224
Sierra Leone
209
Liberia
186
Western and Central Europe
172
Ethiopia
167
Nigeria
160
Uganda
154
Congo, Democratic Republic of
151
Africa
129
Malawi
118
Tanzania
117
Rwanda
112
Nepal
110
Latin America and the Carribbean
106
Senegal
101
Zambia
100
Myanmar / Burma
94
Ghana
93
Bangladesh
92
Germany
83
Syria
83
Guinea
82
Burkina Faso
78
Haiti
77
Ukraine
76
Namibia
63
Eastern Europe
61
West and Central Africa
60
Benin
58
Philippines
57
Cambodia
52
Mozambique
50
East and Southern Africa
50
South–East Asia Region
50
Zimbabwe
47
South Sudan
47
Cameroon
46
Lesotho
46
Russia
44
Asia
42
Middle East and North Africa
41
Brazil
39
Mali
37
Madagascar
37
Indonesia
34
Botswana
32
Eastern Europe and Central Asia
30
Côte d’Ivoire / Ivory Coast
25
Central African Republic
25
Yemen
23
Venezuela
23
USA
21
Eswatini/ Swaziland
21
Colombia
19
Niger
17
Togo
15
Pakistan
15
Western Pacific Region
15
Tajikistan
15
Peru
14
Somalia
13
Afghanistan
13
Chad
13
Angola
13
Thailand
12
Sudan
12
Vietnam
12
Iraq
11
Lebanon
11
Albania
11
Georgia
11
Sri Lanka
10
Laos
10
Jordan
9
China
9
Bolivia
9
Moldova
9
United Kingdom
9
Argentina
8
Ecuador
8
Chile
8
Palestine
8
Southern Africa
8
Burundi
7
North America
7
Spain
7
Guinea-Bissau
6
Turkey
6
North Macedonia
6
Switzerland
6
Mexico
6
France
6
Morocco
5
Paraguay
5
Armenia
5
Canada
5
Jamaica
5
Gambia
4
Hungary
4
Bhutan
4
Poland
4
Congo-Brazzaville
4
Kyrgyzstan
4
Kazakhstan
4
Ireland
3
Papua New Guinea
3
Serbia
3
Honduras
3
El Salvador
3
Greece
3
Libya
3
Italy
3
Timor Leste/ East Timor
3
Romania
3
Uzbekistan
3
Saudi Arabia
2
Malaysia
2
Singapore
2
Guatemala
2
Fiji
2
Bulgaria
2
Estonia
2
Lithuania
2
Slovakia
2
Iran
2
Australia
2
Gabon
2
Belgium
2
Mauritius
2
Tunisia
2
Portugal
2
Egypt
1
Mauritania
1
Austria
1
Nicaragua
1
Other region
1
Luxembourg
1
Solomon Islands
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Norway
1
South Korea
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
United Arab Emirates
1
Authors & Publishers
Publication Years
Category
Countries
3248
Clinical Guidelines
783
Public Health
466
Women & Child Health
367
Key Resources
274
Capacity Building
197
Pharmacy & Technologies
117
Annual Report MEDBOX
2
Protection & Security
1
Toolboxes
COVID-19
962
Mental Health
706
HIV
648
TB
561
Ebola
417
Caregiver
319
Rapid Response
311
AMR
300
NTDs
233
Pharmacy
201
Refugee
193
NCDs
186
Conflict
176
Disability
171
Planetary Health
133
Global Health Education
86
Cholera
80
Zika
66
Natural Hazards
64
Specific Hazards
53
Polio
44
Health Financing Toolbox
38
Social Ethics
29
Typhoon
3
South Sudan
1
Health Financing
1
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional TB treatment ...
Policy Brief November 2021 Available in English, Spanish and Portuguese
The COVID-19 pandemic has fueled the ongoing antimicrobial resistance (AMR) global crisis due to the increase in the use of antibiotics to treat COVID-19 patients, disruptions...
This regional report on the situation of tuberculosis (TB) in the Americas contains information from 2019, provided by the countries of the Region through the World Health Organization TB data collection system. These data have been consolidated and...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The ...-centred platform aims to facilitate clinical research, provide a forum for technical discussions, develop a critical mass of expertise, and strengthen institutional research capacities. In addition, it identifies and reviews priority needs, works towards standardization of methodology to assess drug efficacy and reviews alternatives for using current approved drugs (new schemes, doses, combination) and special scenarios (resistance).
The purpose of this document is to contribute to improved recognition of Buruli
ulcer (Mycobacterium ulcerans infection) and encourage greater efforts in detecting
cases at an early stage of infection.Today, patients can be cured with antibiotics ...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in ... with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, th...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in governm...
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifes...
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better ...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries...
The messages should be used to inform, educate and engage different audience groups depending on their level of risk, vulnerability, presence in contact areas, care of patients with Ebola, or engagement or attendance of burials.
Handbook of HUMANITARIAN HEALTH CARE LOGISTICS Designing the Supply Network and Managing the Flows of Information and Health Care Goods in Humanitarian Assistance during Complex Political Emergencies
This What Matters? edition focuses on Covid-19 rumours circulating in the Rohingya camps of Cox’s Bazar. It explores some of the more common rumours, discusses sources and formats of information, presents community perspectives about rumours and c...
As the Coronavirus pandemic heightens, ESCAP is sourcing guidelines, recommendations and information in various languages to help exchange knowledge on dealing with mental health in children and adolescent during this time.
Documents in multiple l...
28 January 2021. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients.
Défis et progrès. ce rapport présente l’information la plus à jour sur l’incidence de la grossesse non planifiée et de l’avortement à Kinshasa (République démocratique du Congo). La publication du Protocole de Maputo au Journal offici...
The National Asthma Education Programme (or NAEP for short) was started in 2008. We are a registered Non-Profit Organisation that aims to disseminate impartial information about asthma diagnosis and treatment to health professionals and the South Af...
Ce document d'orientation est destiné aux cliniciens qui s'occupent de patients atteints de COVID-19 à toutes les phases de leur maladie (c'est-à-dire du dépistage à la sortie de l'hôpital). Cette mise à jour a été étendue pour répondre ...
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated from each other, and from other circulating arboviral...
